Search

Search Constraints

You searched for: Author/Creator Stuschke, Martin

Search Results

1. 231: Clinical Outcome after Multicenter, Open-Label Phase II Trial on Post-Surgery Chemoradiation in Combination with Cetuximab in Squamous Cell Carcinoma of the Head and Neck with High-Risk of Locoregional Recurrence. (September 2016)

2. A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling. Issue 1 (December 2017)

3. ACTR-49. PriCoTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA. (5th November 2018)

4. Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapy. (February 2022)

6. Antitumor immune response is associated with favorable survival in GEP-NEN G3. Issue 10 (2nd September 2021)

7. Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC – Hypothesis generation on a multicentre cohort of the DKTK-ROG. (April 2022)

8. BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy. (May 2021)

10. CD8+ tumour‐infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK‐ROG). Issue 1 (30th July 2015)